Association between depression and adherence to highly active antiretroviral therapy among adult HIV infected patients in Thailand

Asian Biomedicine

Volumn 3, Issue 2, 2009, Pages 127-133

  Buathong, Napakkawat ^a   Hiransuthikula, Narin ^b   Tangwongchaib, Sookjareon ^b   Komoltric, Chulaluk ^c  

^a Department of Preventive and Social Medicine ^*

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adherence; Depression; Highly active antiretroviral therapy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SOCIAL SUPPORT; THAILAND;

EID: 70349335884     PISSN: 19057415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mocroft A, Vella S, Benfield TL. Changing patterns of mortality across Europe in patients infected with HIV-1. Euro SIDA study group. Lancet. 1998; 352: 1725-1730.
2. Muangchana K, Somton P and Prommool W. Antiretroviral drug taking behaviors of HIV/AIDS outpatients in Bamrasnaradura Institute, 2003. Disease Control J. 2004; 30:18-27.
3. th Worlds AIDS Conf. Abstract 32375.Geneva. 1998.
4. th Conference on Retroviruses and Opportunistic Infections. Abstract 108. Chicago. 1999.
5. th Worlds AIDS Conf. Abstract 32403. Geneva. 1998.
6. Singh N, Squier C, Sivek M, Wagener M, Nguyen H, Yu VL. Determinants of compliance with HAART therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS. 1996; 8:261-269.
7. Bond W, Hussar DA. Detection methods and strategies for improving medication adherence. Am J Public Health. 1991; 47:1978-1988.
8. Erlen JA, Mellors P. Adherence to combination therapy in persons living with HIV: balancing the hardship and the blessing. J Assoc Nurses AIDS. 1999; 10:75-84.
9. Reungtrakul S. Acquired Immunofeficiency Syndrome- Therapy. Bangkok: Rernkaerw, 2005: p. 53.
10. AETC: National Resource Center. Adverse reactions to HIV Medication. Available from:http://www.aidsed. org/aidsetc?page=cm-313-adverse. [cited 2008 june11].
11. Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Effects of cognitive dysfunction and regimen complexity. Am Acad Neurol. 2002; 59: 1944-1950.
12. Tucker JS, Burham MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003; 114:573-580.
13. Power R, Koopman C, Volk J, Israelski DM, Stone L, Chesney MA, et al. Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patients Care STDS. 2003; 17: 245-252.
14. Chesney MA, Ickovic JR, Chamber DB, Gifford NJ, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments patient care committee & adherence working group of the outcome committee of the AACTG. AIDS Care. 2000; 21:255-266.
15. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of beck depression inventories-IA and II in psychiatric out patients. J Personality Assessment. 1996; 67: 588-597.
16. Nasreddine ZS, Phillips NA, Bedirian V. The montreal cognitive assessment (MoCA): A screening tool for mild cognitive impairment. J Am Geiratr Soc. 2004; 53: 695-699.
17. Saunders J, Aasland O. WHO collaborative project on identification and treatment of persons Harmful Alcohol Consumption: report on phase/development of a screening instrument. Geneva:WHO Div Mental Health. 1987.
18. Bakken S, Holzemer WL, Brown MA, Powell-Cope GM, Turner JG, Inouye J, et al. Relationship between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/ AIDS. AIDS Patient Care STDS. 2000; 14:189-97.
19. Jiamton S, Kongsin S, Mahahhranukrao B, Jaffar S. Use of herbs among HIV-infected Thai individuals: A crossectional study from Thailand. Thai AIDS J. 2006; 18:172.
20. Sarna A, Pujari S, Sengar AK, Garg R, Gupta I, Van Dam J. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. Indian J Med Res. 2008; 127:28-36.
21. Bangsberg DR, Perry S, Charlebois ED, Karasic DH, Sorensel JL, Clark RA, et al. Depression symptoms (DS) predict HAART adherence, duration, unstructured treatment interruption and viral suppression. Intersci Cont Antimicrob Agents Chemother.2001; 41: abstract no. I-1721.
22. th ed. Washington DC:American Psychiatric Association, 1994.
23. Whooley MA, Simon GE. Managing depression in medical out patient. N Eng J Med. 2000:343:1942-50.
24. Arnsten JH, Demas PA, Farzadegan H. Antiretroviral therapy adherence and viral suppression in HIVinfected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001; 33: 1417-1423.